UroMed Reliance European roll-out to begin in Germany later this month.
This article was originally published in The Gray Sheet
Executive Summary
UROMED/ASTRA RELIANCE INSERT MARKETING AGREEMENT commits Astra Tech to invest a minimum of $16 mil. toward the female urinary incontinence device's introduction and marketing in six European countries over a five-year period, UroMed announced Sept. 6. The total investment by Astra Tech, a unit of Swedish pharmaceutical manufacturer Astra AB, could approach $31 mil. over the life of the deal.